MicroTech Medical (02235) Announces H-Share Repurchase and Adjusted Treasury Shares

Bulletin Express
02/16

MicroTech Medical (Hangzhou) Co., Ltd. (stock code: 02235) announced a repurchase of 10,800 H shares on 16 February 2026 through the Hong Kong Stock Exchange, with the highest repurchase price at HKD 7.35 and the lowest at HKD 7.26 per share, totaling HKD 78,930.

The company’s opening balance on 9 February 2026 showed 165.74 million shares in issue and 3.43 million treasury shares, out of a total of 169.18 million shares. After the repurchase, issued shares (excluding treasury shares) stood at 165.73 million, while treasury shares rose to 3.44 million. The total share capital remained 169.18 million shares.

This repurchase was conducted under a mandate approved on 28 May 2025, which authorized repurchases of up to 16.67 million shares. Since the mandate was granted, the company has repurchased a total of 891,400 shares, representing 0.53% of the issued share base on the approval date. The new-share issuance moratorium now extends to 16 March 2026.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10